- Home
- VIRC vs OBIO Comparison
VIRC vs OBIO Comparison
Compare VIRC & OBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIRC
- OBIO
- Stock Information
- Founded
- VIRC 1950
- OBIO 2017
- Country
- VIRC United States
- OBIO United States
- Employees
- VIRC N/A
- OBIO N/A
- Industry
- VIRC Industrial Specialties
- OBIO Medicinal Chemicals and Botanical Products
- Sector
- VIRC Consumer Discretionary
- OBIO Health Care
- Exchange
- VIRC Nasdaq
- OBIO Nasdaq
- Market Cap
- VIRC 128.3M
- OBIO 118.8M
- IPO Year
- VIRC N/A
- OBIO N/A
- Fundamental
- Price
- VIRC $8.10
- OBIO $3.12
- Analyst Decision
- VIRC
- OBIO Strong Buy
- Analyst Count
- VIRC 0
- OBIO 5
- Target Price
- VIRC N/A
- OBIO $14.20
- AVG Volume (30 Days)
- VIRC 75.3K
- OBIO 127.6K
- Earning Date
- VIRC 09-08-2025
- OBIO 08-11-2025
- Dividend Yield
- VIRC 1.23%
- OBIO N/A
- EPS Growth
- VIRC N/A
- OBIO N/A
- EPS
- VIRC 1.25
- OBIO N/A
- Revenue
- VIRC $253,259,000.00
- OBIO $2,886,000.00
- Revenue This Year
- VIRC $0.81
- OBIO $20.47
- Revenue Next Year
- VIRC $4.56
- OBIO $11.45
- P/E Ratio
- VIRC $6.52
- OBIO N/A
- Revenue Growth
- VIRC N/A
- OBIO 30.23
- 52 Week Low
- VIRC $7.79
- OBIO $2.37
- 52 Week High
- VIRC $18.50
- OBIO $7.62
- Technical
- Relative Strength Index (RSI)
- VIRC 49.15
- OBIO 50.69
- Support Level
- VIRC $7.92
- OBIO $3.05
- Resistance Level
- VIRC $8.52
- OBIO $3.53
- Average True Range (ATR)
- VIRC 0.32
- OBIO 0.18
- MACD
- VIRC 0.03
- OBIO 0.01
- Stochastic Oscillator
- VIRC 42.47
- OBIO 35.94
About VIRC Virco Manufacturing Corporation
Virco Manufacturing Corp is engaged in designing, production and distributing quality furniture for the commercial and education markets. The company manufactures an assortment of products, including mobile tables, mobile storage equipment, desks, computer furniture, chairs, and activity tables, folding chairs, and folding tables. Its primary furniture lines are constructed of tubular metal legs and frames, combined with wood and plastic tops, plastic seats and backs, upholstered seats and backs, and upholstered rigid polyethylene and polypropylene shells.
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.